These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 1346584)

  • 1. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
    Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
    J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1-0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p.
    Aarts M; Dannenberg H; deLeeuw RJ; van Nederveen FH; Verhofstad AA; Lenders JW; Dinjens WN; Speel EJ; Lam WL; de Krijger RR
    Genes Chromosomes Cancer; 2006 Jan; 45(1):83-93. PubMed ID: 16215979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.
    Takai S; Tateishi H; Nishisho I; Miki T; Motomura K; Miyauchi A; Kato M; Ikeuchi T; Yamamoto K; Okazaki M
    Jpn J Cancer Res; 1987 Sep; 78(9):894-8. PubMed ID: 2889715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene and growth factor expression in MEN 2 and related tumors.
    Moley JF; Wallin GK; Brother MB; Kim M; Wells SA; Brodeur GM
    Henry Ford Hosp Med J; 1992; 40(3-4):284-8. PubMed ID: 1362425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
    Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
    Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
    Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
    Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
    Yang KP; Nguyen CV; Castillo SG; Samaan NA
    Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma.
    Edström Elder E; Nord B; Carling T; Juhlin C; Bäckdahl M; Höög A; Larsson C
    World J Surg; 2002 Aug; 26(8):965-71. PubMed ID: 12045857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
    Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
    Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome.
    Lui WO; Chen J; Gläsker S; Bender BU; Madura C; Khoo SK; Kort E; Larsson C; Neumann HP; Teh BT
    Oncogene; 2002 Feb; 21(7):1117-22. PubMed ID: 11850829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
    Herfarth KK; Wick MR; Marshall HN; Gartner E; Lum S; Moley JF
    Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping of chromosome 1p and 22q in pheochromocytoma.
    Shin E; Fujita S; Takami K; Kurahashi H; Kurita Y; Kobayashi T; Mori T; Nishisho I; Takai S
    Jpn J Cancer Res; 1993 Apr; 84(4):402-8. PubMed ID: 8514606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
    Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
    Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of heterozygosity for markers on chromosome arm 10q in chondrosarcomas.
    Raskind WH; Conrad EU; Matsushita M
    Genes Chromosomes Cancer; 1996 Jun; 16(2):138-43. PubMed ID: 8818661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome.
    Samaan NA; Yang KP; Schultz P; Hickey RC
    Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.